A pair of bipartisan lawmakers in the US Congress have sent a letter to the Biden Administration saying they are “deeply troubled” with a lack of progress following Biden’s 2022 executive order meant to streamline marijuana research and remove barriers.
The letter was signed by Congressmembers Earl Blumenauer (D-OR) and Andy Harris (R-MD), and sent to Xavier Becerra, Secretary of the US Department of Health and Human Services (HHS) and Anne Milgram, Chief Administrator of the Drug Enforcement Administration (DEA).
“President Biden signed our Medical Marijuana and Cannabidiol Research Expansion Act (Public Law No. 117-215) into law on December 2, 2022 – representing a historic breakthrough in addressing the federal government’s misguided restriction of research on the impacts of cannabis”, begins the letter. “At a time when more than half of Americans reside in a place where adult-use of cannabis is legal at the state or local level, and there are four million registered medical marijuana users with many more likely to self-medicate, it is essential that we are able to fully study the impacts of cannabis use.”
Continue reading